Analyst Ratings for Gemini Therapeutics Inc. (GMTX)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2 / 10
Percentile Rank: 15%
Rating Score: 2 / 10
Percentile Rank: 15%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/11/2022 | H.C. Wainwright | Matthew Caufield | Downgrade | Neutral (Buy) |
2.00 (N/A) |
1.49 (1.35) |
-9.4% | Details |
| 3/3/2022 | Leerink Partners | Marc Goodman | Downgrade | Market Perform (Outperform) |
2.00 (10.00) |
1.40 (1.35) |
-3.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
